RUXIENCE conc perf 500 mg/50ml vial 50 ml
7680697010020
CH-69701
L01FA01
07.16.1.
Reimbursement limitations:
RUXIENCE.01
Hématologie:
Traitement de patients symptomatiques non prétraités avec lymphome non hodgkinien folliculaire CD20-positif (stades III-IV) …
1 / 3
google
Details
- Product number
- 6970102
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- rituximabum 500 mg, histidinum, histidini hydrochloridum monohydricum, dinatrii edetas corresp. natrium 0.35 mg, polysorbatum 80, saccharum, aqua ad iniectabile q.s. ad solutionem pro 50 ml.
Articles (1)
Ruxience 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.35 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1159.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2025
Authorization holder
Pfizer AG
8052 Zürich
Authorization information
- Swissmedic authorization number
- 69701
- Drug name
- Ruxience, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01FA01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/08/2024
- Authorization expiration date
- 18/08/2029
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- RUXIENCE conc perf 500 mg/50ml vial 50 ml
- Description (DE)
- RUXIENCE Inf Konz 500 mg/50ml Vial 50 ml
- Market launch
- 19/08/2024
- Narcotic (BTM)
- No